Reversible Suppression of Lymphoproliferation and Thrombocytopenia with Rapamycin in a Patient with Common Variable Immunodeficiency

J Clin Immunol. 2018 Feb;38(2):159-162. doi: 10.1007/s10875-018-0477-z. Epub 2018 Jan 19.

Elissa K Deenick^{1

2}, Adrienne Morey³, Mark Danta², Louise Emmett⁴, Keith Fay⁵, Gary Gracie⁶, Cindy S Ma^{1

2}, Rebecca Macintosh⁷, Sandy A B C Smith⁸, Sarah C Sasson⁸, William A Sewell⁸, Mark Cowley⁹, Stuart G Tangye^{1

2}, Anthony D Kelleher¹⁰; CIRCA; Tri G Phan^{11

12}

¹ Immunology Division, Garvan Institute of Medical Research, Sydney, Australia.
² St Vincent's Clinical School, UNSW Sydney, Sydney, Australia.
³ Department of Anatomical Pathology, ACT Pathology, Canberra Hospital, Garran, Canberra, Australia.
⁴ Department of Nuclear Medicine, St Vincent's Hospital, Sydney, Australia.
⁵ Department of Haematology, Kinghorn Cancer Centre, Sydney, Australia.
⁶ Department of Anatomical Pathology, St Vincent's Hospital, Sydney, Australia.
⁷ Sydney Children's Hospital, Randwick, Sydney, Australia.
⁸ SydPath, St Vincent's Hospital, Sydney, Australia.
⁹ Kinghorn Centre for Clinical Genomics, Garvan Institute of Medical Research, Darlinghurst, Australia.
¹⁰ Kirby Institute, UNSW Sydney, Sydney, Australia.
¹¹ Immunology Division, Garvan Institute of Medical Research, Sydney, Australia. t.phan@garvan.org.au.
¹² St Vincent's Clinical School, UNSW Sydney, Sydney, Australia. t.phan@garvan.org.au.

No abstract available

Publication types